(Q43501489)

24 November 2017

title

Synthetic analogue of bone mineral formation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1055747

17 August 2022

author name string

A. S. Posner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1055747

17 August 2022

N. C. Blumenthal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1055747

17 August 2022

A. L. Boskey

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1055747

17 August 2022

F. Betts

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1055747

17 August 2022

language of work or name

English

0 references

publication date

1 June 1975

1 reference

Journal of Dental Research

24 November 2017

published in

1 reference

24 November 2017

volume

54 Spec No B

1 reference

24 November 2017

page(s)

B88-93

1 reference

The Cellular Basis of Metabolic Bone Disease

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F00220345750540023301

Effects of synthetic salmon calcitonin in patients with Paget's disease of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345750540023301

The Acute Response to Calcitonin in Paget's Disease: Its Relationship to the Serum Alkaline Phosphatase Level and the Effect of Phosphate Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345750540023301

Acute effects of calcitonin on bone formation in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345750540023301

25-hydroxycholecalciferol. A biologically active metabolite of vitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345750540023301

Identification of 1,25-dihydroxycholecalciferol, a form of vitamin D3 metabolically active in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345750540023301

1,25-dihydroxycholecalciferol: identification of the proposed active form of vitamin D3 in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345750540023301

Regulation of vitamin-D metabolism without parathyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345750540023301

Control of 25-hydroxycholecalciferol metabolism by parathyroid glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345750540023301

The control of 25-hydroxyvitamin D metabolism by inorganic phosphorus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345750540023301

Isolation and identification of 24,25-dihydroxycholecalciferol, a metabolite of vitamin D made in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345750540023301

The role of vitamin D metabolites in bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345750540023301

The localization of 1,25-dihydroxycholecalciferol in bone cell nuclei of rachitic chicks

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345750540023301

Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D, in uremic man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345750540023301

Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345750540023301

Biological activity of 1alpha-hydroxycholecalciferol, a synthetic analog of the hormonal form of vitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345750540023301

Parathyroid hormone in plasma in adenomatous hyperparathyroidism, uremia, and bronchogenic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345750540023301

Immunologic differentiation of primary hyperparathyroidism from hyperparathyroidism due to nonparathyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345750540023301

Prostaglandin production by mouse fibrosarcoma cells in culture: Inhibition by indomethacin and aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345750540023301

Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E 2 . A new model for the hypercalcemia of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345750540023301

Prostaglandins: Effect on plasma calcium concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345750540023301

The physiology of prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345750540023301

Human Lymphoproliferative Reaction to Saliva and Dental Plaque-Deposits: An In Vitro Correlation with Periodontal Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345750540023301

Bone-Resorbing Activity in Supernatants from Lymphoid Cell Lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345750540023301

1agr-Hydroxy Derivative of Vitamin D3: A Highly Potent Analog of 1agr,25-Dihydroxyvitamin D3

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345750540023301

Identification of 1,25-Dihydroxycholecalciferol, a New Kidney Hormone controlling Calcium Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345750540023301

10.1177/00220345750540023301

21 January 2018

Identifiers

DOI

1 reference

24 November 2017

1 reference